Misra Tushar
SVP, Chief Manuf. Officer at Mersana Therapeutics, Inc.
- Sold, on record
- $27k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jan 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mersana Therapeutics, Inc.SVP, Chief Manuf. Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Mersana Therapeutics, Inc.UnusualAug 17, 2022 2022
Sold 1,879 shares at $7.10 ($13k)
Misra Tushar, Chief Manufacturing Officer
Sold 30.1% of holdings ($44k position)4,371 shares leftFirst sale on recordFiling
- 2 Form 4 sale Mersana Therapeutics, Inc.Plan not statedJan 17, 2023 +153 days
Sold 458 shares at $5.74 ($3k)
Misra Tushar, SVP, CMO
Sold 7.2% of holdings ($37k position)5,930 shares leftFiling
- 3 Form 4 sale Mersana Therapeutics, Inc.RoutineAug 17, 2023 +212 days
Sold 1,908 shares at $1.18 ($2k)
Misra Tushar, SVP, Chief Manuf. Officer
10b5-1 planSold 14.2% of holdings ($16k position)11,507 shares leftFiling
- 4 Form 4 sale Mersana Therapeutics, Inc.RoutineJan 16, 2024 +152 days
Sold 3,357 shares at $2.71 ($9k)
Misra Tushar, SVP, Chief Manuf. Officer
10b5-1 planSold 15.7% of holdings ($58k position)17,966 shares left1.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 17, 2024 | Mersana Therapeutics, Inc. | SVP, Chief Manuf. Officer | Form 4 sale | 3,357 | $9k | 15.7% | Routine | SEC |
| Aug 17, 2023 | Aug 18, 2023 | Mersana Therapeutics, Inc. | SVP, Chief Manuf. Officer | Form 4 sale | 1,908 | $2k | 14.2% | Routine | SEC |
| Jan 17, 2023 | Jan 18, 2023 | Mersana Therapeutics, Inc. | SVP, CMO | Form 4 sale | 458 | $3k | 7.2% | Plan not stated | SEC |
| Aug 17, 2022 | Aug 18, 2022 | Mersana Therapeutics, Inc. | Chief Manufacturing Officer | Form 4 sale | 1,879 | $13k | 30.1% | Unusual | SEC |